Peter G. Samuels has served as co-head of the Firm’s Mergers & Acquisitions Group, and handles mergers and acquisitions, joint ventures, cross-border transactions, change of control transactions, minority investments and other complex transactions. He regularly advises Boards of Directors, management and shareholders on difficult and demanding issues and transactions.
Peter has been featured as the "Dealmaker in the Spotlight" by the American Lawyer. He is a frequent lecturer on a wide variety of legal topics, and has acted as chair and member of panels for the Practising Law Institute, University of Pennsylvania Law School, the Wharton School, the European American Chamber of Commerce, the Association of Corporate Counsel, and other sponsors.
Peter plays a leading role with respect to Proskauer’s pro bono initiatives relating to various criminal justice programs, including reform of New York’s pretrial release and bail systems and other efforts to reduce incarceration. He serves on the Independent Commission on New York City Criminal Justice and Incarceration Reform, which has played a leading role in the city’s ongoing efforts to close its Rikers Island jails. He is a member of the Board of Directors of The Fedcap Group, a large multi-faceted not-for-profit, with programs relating to workforce development, education and economic development, where he is involved in many programs, including Fedcap's initiative to reduce the number of women detained in Rikers Island through a holistic combination of social service programs. He is also a member of the Board of Directors of Argus Community Inc., a not-for-profit housing a number of high quality and innovative drug treatment and similar programs.
Education
-
Harvard Law School, J.D.
cum laude
-
Columbia University, Columbia College, B.A.
Admissions & Qualifications
- New York
Memberships
New York City Bar (Mergers & Acquisitions Committee)
Matters
- Grifols S.A.’s $1.9 billion strategic alliance with Shanghai RAAS Blood Products Co., Ltd., China’s leading blood plasma company, pursuant to which Grifols exchanged a minority interest in its Grifols Diagnostic subsidiary for a 26.2% stake in Shanghai RAAS. The transaction was named a China Deal of the Year by the Chinese Business Law Journal
- Saddle Point Management, L.P. in its investment in Stericycle Inc., including the settlement agreement under which two of its nominees joined Stericycle’s board of directors
- Grifols $1.85 billion acquisition of Hologic, Inc.’s donor screening business
- Bed Bath & Beyond in its $580 million acquisition of the Cost Plus, Inc. retail chain
- Various Bed Bath retail and other private company acquisitions, including the acquisition of buybuy Baby, Christmas Tree Shops, Harmons, Harbor Linens, Of a Kind, and Chef Central
- Neuberger Berman in its repurchase of Lehman Brothers’ approximately $1.5 billion stake in Neuberger, the world’s largest asset management M&A transaction for the year. The transaction followed our representation during the Lehman Brothers bankruptcy regarding Neuberger’s proposed sale to private equity buyers and subsequent complex management buyout
- Grifols S.A.’s $1.7 billion acquisition of Novartis’s worldwide transfusion diagnostics business
- Grifols in various collaboration and equity investment transactions, including transactions with Aradigm Corporation, Alkahest, Inc., Singulex, Inc., Interstate Blood Bank, Inc., Access Biologicals, L.L.C., and Medkeeper
- Grifols’ $4 billion acquisition of Talecris Biotherapeutics. Described as the world’s largest leveraged buyout since the financial crisis, the transaction was highlighted as a Private Equity Deal of the Year by The Deal magazine and featured by the Financial Times in its inclusion of Proskauer in its list of most innovative U.S. law firms